ArticleFrontiers in research metrics and analytics2022
Shaping the Qualities, Values and Standards of Science. How Reporting Guidelines Improve the Transparency of Biomedical Research.
Article in Frontiers in research metrics and analytics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A plan for systematic reviews for high-need areas in forensic science.Forensic science international. Synergy · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is scientific quality and how can it be achieved? Recent developments in clinical biomedicine gave prominence to transparency as a new core value for scientific research. Without transparency, other characteristics and values remain unknown. But how can abstract concepts and values be implemented in day-to-day scientific practices and what gets lost on the way? In order to answer this question, this study investigates the role of the PRISMA reporting guideline for writing systematic reviews and meta-analyses. By combining a document analysis and expert interviews with its developers, it attempts to bridge the gap between research practice and current modes of evaluation. Beside showing how the guideline was designed to be applicable and acceptable as a new standard, the analysis revealed crucial distinctions between transparency as an abstract quality goal and its practical implementation in the form of specifically formulated rules. Although PRISMA relies on transparency in order to be meaningful, it blurs the concept in order to circumvent some of its main disadvantages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.